UnitedHealth Group (NYSE:UNH) Shares Down 3.3% – Here’s Why

UnitedHealth Group Incorporated (NYSE:UNH)’s share price fell 3.3% during mid-day trading on Thursday. The company traded as low as $394.08 and last traded at $395.7410. Approximately 6,856,144 shares changed hands during mid-day trading, a decline of 5% from the average daily volume of 7,241,529 shares. The stock had previously closed at $409.38.

Trending Headlines about UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealth’s third-quarter adjusted EPS of about $4.69 and revenue above $113 billion topped expectations. The results are bolstering confidence that margins may be recovering, though investors will want evidence that medical-cost pressure is easing sustainably. UnitedHealth Q3 earnings lift confidence in margin recovery
• Positive Sentiment: The board declared a quarterly dividend of $2.32 per share, equivalent to $9.28 annually and a stated yield of 2.3%. The payment is scheduled for December 15 to shareholders of record December 7. UnitedHealth authorizes quarterly dividend
• Positive Sentiment: Zacks highlighted UNH as a long-term momentum stock, which may support investor interest, although the article focuses on its rating framework rather than announcing a new company development. Why UnitedHealth is a top momentum stock for the long term
• Neutral Sentiment: A possible shift toward cyclical stocks and expectations of political gridlock could put healthcare insurers, including UNH, in focus. The outlook depends on policy developments and investor sector preferences. Cyclical stocks and potential political shifts
• Negative Sentiment: Senator Elizabeth Warren renewed calls for scrutiny of UnitedHealth’s growing reach following the Amedisys deal, while Mark Cuban warned that AI could disrupt large healthcare companies. These comments add regulatory and longer-term business-model uncertainty, but the articles do not report a new regulatory action. UnitedHealth faces breakup pressure and AI concerns

Wall Street Analyst Weigh In

UNH has been the topic of a number of analyst reports. Barclays cut their price target on UnitedHealth Group from $441.00 to $440.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 14th. Stephens set a $500.00 price objective on UnitedHealth Group in a report on Friday, October 16th. Leerink Partners boosted their target price on UnitedHealth Group from $462.00 to $472.00 and gave the stock an “outperform” rating in a research note on Friday, July 17th. TD Cowen reaffirmed a “hold” rating and issued a $402.00 price target on shares of UnitedHealth Group in a report on Thursday, October 15th. Finally, BMO Capital Markets set a $512.00 price target on shares of UnitedHealth Group in a research note on Tuesday, July 21st. Twenty analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company’s stock. According to data from MarketBeat, UnitedHealth Group has a consensus rating of “Moderate Buy” and a consensus target price of $463.93.

UnitedHealth Group Trading Down 3.3%

The firm has a market capitalization of $355.21 billion, a price-to-earnings ratio of 22.60, a price-to-earnings-growth ratio of 1.46 and a beta of 0.51. The business’s 50 day moving average price is $390.73 and its 200-day moving average price is $363.43. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.74 and a quick ratio of 0.78.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.14 by $0.55. The company had revenue of $112.72 billion for the quarter, compared to analysts’ expectations of $111.31 billion. UnitedHealth Group had a return on equity of 17.95% and a net margin of 3.53%. The firm’s quarterly revenue was down .4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.59 EPS. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. Equities analysts forecast that UnitedHealth Group Incorporated will post 20.61 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 15th. Investors of record on Monday, December 7th will be given a $2.32 dividend. The ex-dividend date is Monday, December 7th. This represents a $9.28 annualized dividend and a dividend yield of 2.3%. UnitedHealth Group’s payout ratio is currently 53.00%.

Insider Activity at UnitedHealth Group

In related news, CEO Patrick Conway sold 1,169 shares of the stock in a transaction on Friday, August 21st. The stock was sold at an average price of $390.00, for a total transaction of $455,910.00. Following the sale, the chief executive officer owned 15,328 shares of the company’s stock, valued at $5,977,920. This trade represents a 7.09% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.19% of the stock is owned by corporate insiders.

Institutional Trading of UnitedHealth Group

A number of hedge funds have recently added to or reduced their stakes in the business. BlackRock Inc. boosted its position in shares of UnitedHealth Group by 4.6% in the second quarter. BlackRock Inc. now owns 76,863,061 shares of the healthcare conglomerate’s stock worth $31,946,594,000 after buying an additional 3,395,530 shares during the period. State Street Corp raised its holdings in shares of UnitedHealth Group by 0.7% during the 2nd quarter. State Street Corp now owns 45,633,267 shares of the healthcare conglomerate’s stock valued at $18,966,555,000 after buying an additional 301,081 shares during the period. Bank of New York Mellon Corp lifted its position in UnitedHealth Group by 6.1% during the 2nd quarter. Bank of New York Mellon Corp now owns 10,704,994 shares of the healthcare conglomerate’s stock worth $4,449,317,000 after acquiring an additional 616,723 shares in the last quarter. Wellington Management Group LLP lifted its position in UnitedHealth Group by 5.8% during the 2nd quarter. Wellington Management Group LLP now owns 10,675,175 shares of the healthcare conglomerate’s stock worth $4,436,923,000 after acquiring an additional 583,536 shares in the last quarter. Finally, Corient Private Wealth LP boosted its holdings in UnitedHealth Group by 1,443.7% in the 2nd quarter. Corient Private Wealth LP now owns 8,447,224 shares of the healthcare conglomerate’s stock worth $3,510,920,000 after acquiring an additional 7,900,011 shares during the period. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care company that provides health insurance coverage, health care services, pharmacy services and health technology. Its businesses serve individuals, employers, government programs, health care providers and other organizations, primarily in the United States.

The company operates through two principal businesses. UnitedHealthcare offers health benefit plans and related services for employers, individuals, families and government-sponsored programs, including Medicare and Medicaid.